Antibacterial material as well as preparation method and application thereof

By forming an antibacterial material structure with sodium alginate and hyaluronic acid polyanionic layer on the surface of biodegradable polymer materials, the stability and biocompatibility of antibacterial materials are solved, and the stable and sustainable release of antibacterial properties is achieved, reducing the risk of reducing the stability and biocompatibility of antibacterial properties. The toxicity and resistance of antibacterial drugs are achieved.

CN119055838APending Publication Date: 2024-12-03袁明龙 +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410874005.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-01
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing antibacterial materials have unstable antibacterial effects in hospital environments, poor biocompatibility and can easily lead to antibacterial drug resistance problems.

Method used

An antibacterial material structure including a substrate, an antibacterial agent layer and a polyanionic layer is adopted, wherein the polyanionic layer uses sodium alginate and hyaluronic acid to form stable antibacterial on the surface of a biodegradable polymer material through dip coating or layer-by-layer self-assembly technology. coating.

Benefits of technology

The stability and sustainable release of antibacterial properties are achieved, the cytotoxicity of antibacterial agents is reduced, the biocompatibility is improved, and the emergence of antibacterial drug resistance is avoided.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004924555400000011
    Figure HDA0004924555400000011
  • Figure HDA0004924555400000012
    Figure HDA0004924555400000012
  • Figure HDA0004924555400000021
    Figure HDA0004924555400000021
Patent Text Reader

Abstract

The invention discloses an antibacterial material which comprises a substrate, an antibacterial agent layer and a polyanion layer located between the substrate and the antibacterial agent layer, and a polyanion material in the polyanion layer comprises sodium alginate. The invention also discloses a preparation method of the antibacterial material and application of the antibacterial material in medical implants or medical fillers and the like. According to the antibacterial material, the problems that an existing antibacterial material cannot continuously and stably resist bacteria and is poor in biocompatibility, and antibacterial drugs have drug resistance are solved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of polymer materials, and in particular relates to a degradable antibacterial material and a preparation method and application thereof. Background Art

[0002] Polymer materials are usually used in industry, agriculture, daily necessities and food packaging. With the continuous deepening of polymer material research and the continuous improvement of performance, polymer materials have gradually shown their unique advantages in the medical field. Polylactic acid (PLA), as a biomedical material approved by the US Food and Drug Administration (FDA), has been well applied in medical fields such as surgical sutures, drug controlled release, tissue engineering scaffold materials, fracture internal fixation materials, gene therapy carriers, and ophthalmic implant materials by utilizing its own biocompatibility, biodegradability, and non-toxicity. Compared with traditional treatment methods, biodegradable polymer materials have important value in treating and repairing damaged tissues and assisting in the delivery and release of drugs. In addition to biocompatibility, bioabsorbability and biodegradability, degradable polymer materials also have the characteristics of renewability and easy processing, and the raw materials used to prepare them are also non-toxic and harmless.

[0003] The incidence and prevalence of antibiotic resistance in bacterial pathogens in hospital settings are increasing, and resistance genes are also spreading rapidly in the environment, resulting in increased morbidity and mortality and a huge burden on the economy, becoming a major healthcare threat worldwide. The discovery and application of antimicrobial peptides (AMPs) provide an excellent potential strategy to address these threats.

[0004] Antimicrobial peptides are small molecule polypeptides with biological activity induced in organisms. They are strongly alkaline, with a molecular weight of about 2000-7000 and composed of 12-100 amino acid residues. AMP has gradually developed into a research hotspot in biomedicine, veterinary medicine, environmental science and other related fields due to its advantages such as broad antimicrobial spectrum, rapid action, good thermal stability, and low resistance to drug resistance, as well as its excellent therapeutic potential in antibacterial, antiviral, antifungal, anti-inflammatory and anti-tumor aspects. Antimicrobial peptides are widely present in organisms and can help the body resist the invasion of exogenous microorganisms. They are an important component of the innate defense system of organisms. However, AMP is extremely sensitive to proteolytic enzymes, which limits the systemic application of AMP. In addition, due to the particularity of the source of AMP, its own stability is poor and it has certain cytotoxicity. The existing technology cannot effectively improve its cell compatibility and sustained stability. Summary of the invention

[0005] In view of the deficiencies in the prior art, the purpose of the present invention is to provide a simple antibacterial material for the surface of degradable medical implants / fillers, which provides certain conveniences for the preparation of tissue engineering scaffold materials, fracture internal fixation materials, ophthalmic implant materials, etc. with antibacterial properties, and improves the problems of existing antibacterial materials in which they cannot have sustained and stable antibacterial properties, have poor biocompatibility, and have resistance to antibacterial drugs.

[0006] According to one aspect of the present disclosure, an antibacterial material is provided, comprising a substrate, an antibacterial agent layer, and a polyanion layer located between the substrate and the antibacterial agent layer, wherein the polyanion material in the polyanion layer comprises sodium alginate.

[0007] In some embodiments, the polyanionic material in the polyanionic layer further comprises hyaluronic acid.

[0008] In some embodiments, the substrate comprises a biodegradable polymer material. Preferably, the substrate comprises a biodegradable polymer material with a molecular weight of 10,000-5,000,000. In some embodiments, the substrate comprises one or more of polylactic acid (PLA), carbon dioxide polymer (PPC), polybutylene succinate (PBS), aliphatic aromatic polyester Ecoflex (PBAT), polytrimethylene terephthalate (PPT), poly-β-hydroxyalkanoate (PHA), poly-ε-caprolactone (PCL) or polydioxanone (PPDO).

[0009] In some embodiments, the antimicrobial agent in the antimicrobial agent layer includes one or more of an antimicrobial peptide, a glycopeptide antibiotic, or a macrolide antibiotic. Preferably, the antimicrobial agent is selected from an antimicrobial agent with a net positive charge. More preferably, the glycopeptide antibiotic includes one or more of vancomycin, norvancomycin, teicoplanin, polymyxin B, colistin, or bacitracin. Preferably, the macrolide antibiotic includes one or more of erythromycin, spiramycin, josamycin, roxithromycin, clarithromycin, or azithromycin.

[0010] The inventors of the present application have found that sodium alginate can be directly combined with biodegradable polymer materials and antimicrobial agents when used in antimicrobial materials. The inventors have also unexpectedly found that the antimicrobial material of the present application can be further assembled layer by layer into a sustainable release antimicrobial coating of sodium alginate, hyaluronic acid and antimicrobial peptides using hyaluronic acid, which is also a polyanion material, which significantly shortens the time for preparing the antimicrobial material and improves its antimicrobial performance.

[0011] In some embodiments, the polyanion material in the polyanion layer further includes polyacrylic acid, sulfonated dextran, sulfonated polyetheretherketone, polystyrene sulfonic acid or one or more of their salts. Preferably, the salt is selected from one or more of lithium salt, sodium salt, potassium salt, calcium salt, magnesium salt, aluminum salt, iron salt, zinc salt or ammonium salt.

[0012] In some embodiments, the antimicrobial material comprises one or more polyanion layers.

[0013] In some embodiments, the antimicrobial material includes one or more layers of antimicrobial agents.

[0014] In some embodiments, the one or more polyanion layers are spaced apart from the one or more antimicrobial agent layers.

[0015] In some embodiments, the antimicrobial material comprises a polyanion layer containing sodium alginate and an antimicrobial agent layer sequentially stacked on a substrate.

[0016] In some embodiments, the antimicrobial material includes a polyanion layer containing sodium alginate and a combined layer formed of a polyanion layer containing hyaluronic acid and an antimicrobial agent layer sequentially stacked on a substrate.

[0017] In some embodiments, the number of layers of the combination layer is 1-30 layers, preferably 2-10 layers, for example 2 layers, 3 layers, 4 layers, 5 layers, 6 layers, 7 layers, 8 layers, 9 layers or 10 layers.

[0018] According to another aspect of the present disclosure, a method for preparing an antibacterial material is provided, comprising sequentially coating a polyanion layer and an antibacterial agent layer on a substrate.

[0019] In some embodiments, the preparation method comprises coating a polyanion layer and an antimicrobial agent layer on a substrate by dip coating, and the polyanion material in the polyanion layer comprises sodium alginate.

[0020] In some embodiments, the preparation method comprises the following steps:

[0021] A1: providing a building block solution containing a polyanion material and an antimicrobial agent solution containing an antimicrobial agent;

[0022] A2: immersing the substrate in the building element solution;

[0023] A3: Immerse the substrate obtained in A2 in the antibacterial agent solution to obtain the antibacterial material.

[0024] In some embodiments, in step A1, the mass concentration of the polyanion material in the building block solution is 5-200 mg / mL, preferably 10-80 mg / mL. In some embodiments, in step A1, the mass concentration of the polyanion material in the building block solution is 5 mg / mL, 10 mg / mL, 20 mg / mL, 30 mg / mL, 50 mg / mL, 80 mg / mL, 100 mg / mL, 150 mg / mL, 200 mg / mL or any value therebetween.

[0025] In some embodiments, in step A1, the mass concentration of the antibacterial agent in the antibacterial agent is 0.05-25.00 mg / mL, preferably 0.25-2 mg / mL. In some specific embodiments, in step A1, the mass concentration of the antibacterial agent in the antibacterial agent can be 0.05 mg / mL, 0.1 mg / mL, 0.2 mg / mL, 0.25 mg / mL, 0.5 mg / mL, 0.75 mg / mL, 1 mg / mL, 1.25 mg / mL, 1.5 mg / mL, 1.75 mg / mL, 2 mg / mL, 5 mg / mL, 10 mg / mL, 15 mg / mL, 20 mg / mL, 25 mg / mL or any value therebetween.

[0026] In some embodiments, in step A2, the immersion temperature is 25-45°C and the time is 0.5-1.5h. In some specific embodiments, in step A2, the immersion temperature can be 25°C, 30°C, 35°C, 40°C, 45°C or any value therebetween. In some specific embodiments, in step A2, the immersion time can be 0.5h, 0.75h, 1h, 1.25h, 1.5h or any value therebetween.

[0027] In some embodiments, in step A3, the immersion temperature is 15-35°C and the time is 6-24h. In some specific embodiments, in step A3, the immersion temperature can be 15°C, 20°C, 25°C, 30°C, 35°C or any value therebetween. In some specific embodiments, in step A3, the immersion time can be 6h, 10h, 14h, 18h, 22h, 24h or any value therebetween.

[0028] In some embodiments, step A3 further comprises washing and drying the impregnated substrate.

[0029] In some embodiments, the preparation method comprises coating a polyanion layer and an antimicrobial agent layer on a substrate by layer-by-layer assembly, wherein the polyanion material in the polyanion layer comprises sodium alginate and hyaluronic acid.

[0030] In some embodiments, the preparation method comprises: sequentially coating a polyanion layer and an antimicrobial agent layer on a substrate by layer-by-layer self-assembly (LbL) technology.

[0031] In some embodiments, the preparation method comprises the following steps:

[0032] B1: providing a first building block solution containing a first polyanion material, a second building block solution containing a second polyanion material, and an antibacterial agent solution containing an antibacterial agent, wherein the first polyanion material comprises sodium alginate, and the second polyanion material comprises hyaluronic acid;

[0033] B2: immersing the substrate in the first building element solution;

[0034] B3: immersing the substrate obtained in B2 in the second building block solution;

[0035] B4: immersing the substrate obtained in B3 in the antibacterial agent solution;

[0036] B5: Repeat steps B3-B4 to obtain the antibacterial material;

[0037] In some embodiments, the repetition number of B3-B4 is 1-30 times, for example, it can be 1 time, 2 times, 3 times, 5 times, 10 times, 15 times, 20 times, 25 times, 30 times or any value therebetween. In some preferred embodiments, the repetition number of B3-B4 is 2-10 times.

[0038] In some embodiments, in step B1, in the first building block solution, the mass concentration of the first polyanion material is 5-200 mg / mL, preferably 10-80 mg / mL. In some embodiments, in step B1, in the first building block solution, the mass concentration of the first polyanion material is 5 mg / mL, 10 mg / mL, 20 mg / mL, 30 mg / mL, 50 mg / mL, 80 mg / mL, 100 mg / mL, 150 mg / mL, 200 mg / mL or any value therebetween.

[0039] In some embodiments, in step B1, in the second building block solution, the mass concentration of the second polyanion material is 0.1-50 mg / mL, preferably 1-10 mg / mL. In some embodiments, in step B1, in the second building block solution, the mass concentration of the second polyanion material is 0.1 mg / mL, 0.5 mg / mL, 1 mg / mL, 2 mg / mL, 3 mg / mL, 4 mg / mL, 5 mg / mL, 6 mg / mL, 7 mg / mL, 8 mg / mL, 9 mg / mL, 10 mg / mL, 20 mg / mL, 30 mg / mL, 40 mg / mL, 50 mg / mL or any value therebetween.

[0040] In some embodiments, in step B1, the mass concentration of the antibacterial agent in the antibacterial agent is 0.05-25.00 mg / mL, preferably 0.25-2 mg / mL. In some specific embodiments, in step B1, the mass concentration of the antibacterial agent in the antibacterial agent can be 0.05 mg / mL, 0.1 mg / mL, 0.2 mg / mL, 0.25 mg / mL, 0.5 mg / mL, 0.75 mg / mL, 1 mg / mL, 1.25 mg / mL, 1.5 mg / mL, 1.75 mg / mL, 2 mg / mL, 5 mg / mL, 10 mg / mL, 15 mg / mL, 20 mg / mL, 25 mg / mL or any value therebetween.

[0041] In some embodiments, in step B2, the immersion temperature is 25-35°C and the time is 30-60 min. In some embodiments, in step B2, the immersion temperature is 25°C, 27°C, 30°C, 32.5°C, 35°C or any value therebetween. In some embodiments, in step B2, the immersion time is 30 min, 35 min, 40 min, 45 min, 50 min, 55 min, 60 min or any value therebetween.

[0042] In some embodiments, in step B3, the immersion temperature is 15-35°C and the time is 4-30 min. In some embodiments, in step B3, the immersion temperature is 15°C, 20°C, 25°C, 27°C, 30°C, 32.5°C, 35°C or any value therebetween. In some embodiments, in step B3, the immersion time is 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min or any value therebetween.

[0043] In some embodiments, in step B4, the immersion temperature is 15-35°C and the time is 4-30 min. In some embodiments, in step B4, the immersion temperature is 15°C, 20°C, 25°C, 27°C, 30°C, 32.5°C, 35°C or any value therebetween. In some embodiments, in step B4, the immersion time is 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min or any value therebetween.

[0044] In some embodiments, step B5 further comprises washing and drying the substrate after the impregnation.

[0045] In some embodiments, in step A1, a polyanion material is prepared in the presence of a solvent at 25-50° C. to obtain a building block solution.

[0046] In some embodiments, in step A1, an antimicrobial agent is prepared at 15-35° C. in the presence of a solvent to obtain an antimicrobial agent solution.

[0047] In some embodiments, in step B1, in the presence of a solvent, the first polyanion material is prepared at 25-50° C. to obtain a first building block solution. In some embodiments, in the second building block solution, the concentration of the second polyanion material is 5-200 mg / mL, preferably 10-80 mg / mL, and the pH value is 3-13, preferably 5.5-13.

[0048] In some embodiments, in step B1, in the presence of a solvent, the second polyanion material is prepared at 15-35° C. to obtain a second building block solution. In some embodiments, in the second building block solution, the concentration of the second polyanion material is 0.1-50 mg / mL, preferably 1-30 mg / mL, and the pH value is 3-12, preferably 3-6.5.

[0049] In some embodiments, in step B1, the antimicrobial agent is prepared at 15-35° C. in the presence of a solvent to obtain an antimicrobial agent solution.

[0050] In some embodiments, in the antimicrobial agent solution, the concentration of the antimicrobial agent is 0.25-25 mg / mL, preferably 0.5-2 mg / mL, and the pH value is 4-12, preferably 7.5-10.

[0051] In some embodiments, the solvent includes one or more of water, ethanol, acetic acid, acetic acid, hydrochloric acid or Tris.

[0052] In some embodiments, the solvent of the antimicrobial agent is selected from water.

[0053] In some embodiments, the substrate is obtained by polishing, cleaning and drying a substrate material in a desired shape.

[0054] In some embodiments, the substrate material is prepared to a desired size and thickness by a rotary rheometer at 150-200°C.

[0055] In some embodiments, the polishing is performed using sandpaper with a grit of 400-2000. In some embodiments, the sandpaper is SiC sandpaper.

[0056] In some embodiments, the substrate is prepared by a method comprising the following steps:

[0057] (1) preparing a biodegradable polymer material with a molecular weight of 10,000-5,000,000 into a block material of a desired size and thickness by a rotary rheometer;

[0058] (2) The material obtained in (1) is trimmed into a desired shape according to a corresponding mold, and then polished, ultrasonically cleaned and dried to obtain the substrate.

[0059] In some specific embodiments, the method for preparing the antibacterial material by dip coating comprises the following steps:

[0060] (1) placing a container containing a polyanionic material and a solvent in a dual-function gas bath constant temperature oscillator, oscillating for 0.5-2 hours at 25-50° C. and 100-300 r / min to prepare a building block solution containing 1%-20% of the polyanionic material;

[0061] (2) adding an antimicrobial agent such as an antimicrobial peptide / macrolide antibiotic to deionized water and mixing the mixture at room temperature to obtain a corresponding antimicrobial agent solution;

[0062] (3) immersing the treated substrate in a building element solution at 25-45° C. for 0.5-1.5 h, and then taking out the substrate;

[0063] (4) Immersing the substrate coated with the polyanion coating obtained in (3) in an antibacterial solution overnight, then taking out the substrate, washing away the antibacterial molecules not attached to the surface of the substrate with deionized water, and placing the substrate on a sterile table to dry, thereby preparing a uniform antibacterial coating on the degradable substrate to obtain the antibacterial material.

[0064] In other embodiments, the method for preparing the antibacterial material by layer-by-layer assembly comprises the following steps:

[0065] (1) placing a container containing a first polyanion material and a solvent in a dual-function gas bath constant temperature oscillator, oscillating for 0.5-2 hours at 25-50° C. and 100-300 r / min to prepare a first building block solution containing the first polyanion material;

[0066] (2) placing the container containing the second polyanion material and the solvent in a dual-function gas bath constant temperature oscillator, oscillating at 15-35° C. and 100-300 r / min for 0.5-1 h to prepare a second building block solution containing the second polyanion material;

[0067] (3) adding an antimicrobial agent such as an antimicrobial peptide / macrolide antibiotic to deionized water and mixing the mixture at room temperature to obtain a corresponding antimicrobial agent solution;

[0068] (4) immersing the treated substrate in a first building block solution at 25-35° C. for 30-60 min, and then taking out the substrate;

[0069] (5) immersing the substrate removed from step (4) in a second building block solution at 15-35° C. for 4-30 min, and then removing the substrate;

[0070] (6) immersing the substrate removed in (5) into an antimicrobial solution, allowing it to stand for 4-30 minutes, and then removing the substrate;

[0071] Optionally, (7) repeats (5) to (6) 1 to 30 times, preferably 2 to 10 times.

[0072] The present invention adopts a simple dip coating method and layer-by-layer self-assembly preparation technology, based on a polyanion layer, to coat an antibacterial agent with a net positive charge on the surface of a biodegradable substrate to form a stable, sustainable and uniform antibacterial coating. The antibacterial coating prepared by the above method not only has excellent and stable antibacterial properties, but also has sustainable release properties. This is because the electrostatic interaction between the positively charged antibacterial agent residues and the negatively charged phospholipids on the surface of the bacterial membrane kills the bacteria. In addition, the inventors of the present invention surprisingly found that the antibacterial effect of the antibacterial agent coated on the degradable substrate is close to or even better than that of the pure antibacterial agent solution, and the cytotoxicity of the antibacterial agent is also significantly reduced due to the combination with the degradable substrate. The characterization results show that the biodegradable antibacterial material finally prepared by the present invention is non-cytotoxic and has good biocompatibility. The inventors also unexpectedly discovered that the present application utilizes sodium alginate and hyaluronic acid, both of which are polyanionic materials, and not only will there be no repulsion, but the antibacterial agents can be assembled layer by layer into an antibacterial material that can be released sustainably. Moreover, compared with the antibacterial material assembled from polycationic chitosan, the antibacterial material of the present application has a smaller water contact angle and better hydrophilic properties, which is conducive to the practical application of the antibacterial material in clinical practice.

[0073] According to another aspect of the present disclosure, there is provided use of the antibacterial material of the present disclosure or the antibacterial material obtained by the preparation method in medical implants or medical fillers.

[0074] In some embodiments, the medical implant or medical filler includes, but is not limited to, tissue engineering scaffold materials, fracture internal fixation materials, ophthalmic implant materials, and the like.

[0075] The present disclosure has the following beneficial effects:

[0076] 1. The antibacterial effect of the antibacterial material prepared by the present invention is close to or even better than that of the pure antibacterial agent solution, while reducing the toxicity of the antibacterial agent and enhancing the antibacterial stability of the antibacterial agent. The antibacterial material disclosed in the present invention uses a biodegradable polymer material as a substrate, significantly improves the biocompatibility and biodegradability of the antibacterial coating, and also has a certain promoting effect on cell proliferation. In addition, the antibacterial material disclosed in the present invention has sustainable release and shows a sustained antibacterial effect under the condition of immersion in simulated body fluids for many days.

[0077] 2. The antibacterial material disclosed in the present invention is independent of material and is not affected by material type or size. It can be adhered and polymerized on the surface of any material.

[0078] 3. The preparation method of the antibacterial material disclosed in the present invention is simple, the process is easy to operate, the antibacterial agent material does not need to be modified, the reaction conditions are mild, the time is short, and it is easy to achieve large-scale production. BRIEF DESCRIPTION OF THE DRAWINGS

[0079] Figure 1 The field emission scanning electron microscope images of the antibacterial material prepared according to Example 6 of the present application are shown, where A is before coating (material obtained in step S2), B1 is the coating by dip coating (material obtained in step S4-1), and B2 is the layer-by-layer self-assembled coating (material obtained in step S6).

[0080] Figure 2 The results of the bacterial plating experiment of the antibacterial material prepared according to Example 7 of the present application are shown.

[0081] Figure 3 The results of the bacterial plating experiment of the antibacterial material prepared according to Example 8 of the present application are shown.

[0082] Figure 4 The results of the absorbance values ​​of the bacterial solution after co-culturing the antibacterial materials of antibacterial peptides of different concentrations prepared according to Example 9 of the present application and Staphylococcus aureus are shown.

[0083] Figure 5 The results of hemolysis rate determination after the blood compatibility evaluation test of the antibacterial material prepared according to Example 10 of the present application are shown.

[0084] Figure 6 The water contact angle evaluation test results of the antibacterial material prepared according to Example 11 of the present application (experimental group) and the antibacterial material prepared using chitosan (control group) are shown. DETAILED DESCRIPTION

[0085] Biodegradable polymer materials have good biocompatibility, biodegradability, non-toxicity, renewability and easy processing, and are widely used in food, chemical industry and agriculture. Pure biodegradable polymer materials have certain hydrophobicity, brittleness, low toughness, poor dielectric properties and no antibacterial properties, and often need to be modified with other materials before use. Antimicrobial peptides (AMPs) have the advantages of broad-spectrum antibacterial properties and are not easy to develop drug resistance, but they are easily digested by proteolytic enzymes, and their own stability and biocompatibility are poor, which limits their application in the whole body. Dip coating and layer-by-layer self-assembly preparation technology are simple and multifunctional surface modification technologies. Using a simple dip coating method and layer-by-layer self-assembly preparation technology, based on the polyanion building block coating liquid, a uniform antibacterial coating is formed on the surface of the biodegradable medical implant / coating through electrostatic force and hydrogen bonding. Their most important characteristics are stable antibacterial properties, which can achieve sustainable release of antimicrobial agents while improving their biocompatibility. Moreover, as the antimicrobial agents are gradually released, the polymer material substrate will eventually degrade, and the degradation products will be non-toxic and harmless.

[0086] In some embodiments, the present invention provides a simple method for preparing an antibacterial material for degradable medical implants / fillers. The preparation method mainly uses electrostatic force to coat an antibacterial agent (such as antimicrobial peptides / macrolide antibiotics / glycopeptide antibiotics) on a degradable substrate using a polyanion (such as sodium alginate), and specifically involves the use of a simple dip coating method and a layer-by-layer assembly preparation technology alone or in combination. The above method can prepare a dense antibacterial coating on the surface of a degradable substrate. The substrate material carrying the coating has good biocompatibility and degradability, and the degradation product is non-toxic and harmless. Coating the antimicrobial peptide on the surface of the degradable material not only improves the drug resistance problem caused by the abuse of antibiotics, but also makes full use of its own broad-spectrum, stable and sustainable release antibacterial properties, reducing its cytotoxicity when used alone. The method has a simple operation process, mild reaction conditions, short preparation time, low preparation difficulty, is not limited by the shape and material of the substrate, and can be applied to large-scale production. The materials used in the entire invention are non-toxic and harmless, and the solvent used to dissolve the antibacterial agent is only water. The preparation method proposed will provide certain reference value for research in materials science, surface chemistry and other fields, and this highly stable antibacterial coating is expected to be widely used in medical implants / fillers and medical devices.

[0087] In order to make the purpose, technical scheme and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. The specific embodiments described herein are only used to explain the present invention and are not intended to constitute any limitation to the present invention. In addition, in the following description, the description of known structures and technologies is omitted to avoid unnecessary confusion of the concepts of the present disclosure. Such structures and technologies are also described in many publications.

[0088] In the following examples, the biodegradable substrates used in the biodegradable medical implants / fillers are all made of polylactic acid (PLA) as a raw material. The biodegradable substrate can be prepared by the following steps:

[0089] S1. Take 5000g of PLA particles with a molecular weight of 100000 and prepare a block material of the desired size and thickness through a rotary rheometer;

[0090] S2. Take the block material obtained in S1 and trim it into a desired shape according to the corresponding mold, then polish, ultrasonically clean and dry it to obtain a biodegradable substrate that can be used for medical implants / fillers for later use.

[0091] In the following examples, the antimicrobial peptide LL-37 was purchased from Hangzhou Sinoda Pharmaceutical Technology Co., Ltd., and vancomycin was purchased from Sigma.

[0092] The room temperature used in the preparation method ranges from 15 to 35°C.

[0093] Example 1

[0094] Preparation of composite antibacterial coating of sodium alginate and antimicrobial peptide (LL-37) by dip coating:

[0095] 1. Take 200 mL of deionized water in a beaker, then weigh 10 g of sodium alginate and add it to the beaker. Place the beaker in a dual-function air bath constant temperature oscillator and oscillate for 1 hour at 40°C and 150 r / min to prepare a 50 mg / mL building block solution.

[0096] 2. Dissolve LL-37 in deionized water. The concentrations of LL-37 are 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 1.75, and 2.00 mg / mL, respectively;

[0097] 3. Immerse the treated biodegradable substrate in a sodium alginate solution at 35°C for 1.5 hours, and then take out the substrate;

[0098] 4. Immerse the substrate coated with sodium alginate in step 3 in the LL-37 solution at room temperature overnight, then take out the substrate, wash off the unattached LL-37 molecules on the surface of the substrate with deionized water, and place the substrate on a sterile table to dry, thereby preparing a uniform antibacterial coating on the degradable substrate.

[0099] Example 2

[0100] Preparation of composite antibacterial coating of sodium alginate and vancomycin by dip coating:

[0101] 1. Take 200 mL of deionized water in a beaker, then weigh 10 g of sodium alginate and add it to the beaker. Place the beaker in a dual-function air bath constant temperature oscillator and oscillate for 1 hour at 40°C and 150 r / min to prepare a 50 mg / mL building block solution.

[0102] 2. Dissolve vancomycin in deionized water. The concentrations of vancomycin are 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 1.75, and 2.00 mg / mL respectively;

[0103] 3. Immerse the treated biodegradable substrate in a sodium alginate solution at 35°C for 1.5 hours, and then take out the substrate;

[0104] 4. Immerse the substrate coated with sodium alginate in step 3 in a vancomycin solution at room temperature overnight, then take out the substrate, wash off the unattached vancomycin molecules on the surface of the substrate with deionized water, and place the substrate on a sterile table to dry, thereby preparing a uniform antibacterial coating on the degradable substrate.

[0105] Example 3

[0106] Sustained release antibacterial coating of sodium alginate, hyaluronic acid and antimicrobial peptide (LL-37) prepared by layer-by-layer assembly technology:

[0107] 1. Take 150 mL of deionized water in a beaker, then weigh 4.5 g of sodium alginate and add it to the beaker. Place the beaker in a dual-function air bath constant temperature oscillator and oscillate for 0.5 h at 35 ° C and 260 r / min to prepare a 30 mg / mL sodium alginate building block solution;

[0108] 2. Weigh 0.04 g of hyaluronic acid into a centrifuge tube, add 40 mL of deionized water, and stir and mix evenly at 35°C to prepare a 1 mg / mL hyaluronic acid building block solution;

[0109] 3. Dissolve LL-37 in deionized water. The concentrations of LL-37 are 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 1.75, and 2.00 mg / mL, respectively;

[0110] 4. Immerse the treated biodegradable substrate into a 30°C sodium alginate building element solution, let it stand for 45 minutes, and then take out the substrate;

[0111] 5. Immerse the substrate taken out in step 4 into a 25°C hyaluronic acid building element solution, let it stand for 15 minutes, and then take out the substrate;

[0112] 6. Immerse the substrate taken out in step 5 into the LL-37 solution, let it stand at room temperature for 20 minutes, and then take out the substrate;

[0113] 7. After repeating steps 5 to 6 for 10 times, the substrate was taken out, and the unattached LL-37 molecules on the substrate surface were washed off with deionized water. The substrate was placed on a sterile table to dry, and a sustainable release antibacterial coating was prepared on the degradable substrate.

[0114] Example 4

[0115] Preparation of composite antibacterial coating of sodium alginate, hyaluronic acid and antimicrobial peptide (LL-37) by layer-by-layer assembly technology:

[0116] 1. Take 200 mL of deionized water in a beaker, then weigh 16 g of sodium alginate and add it to the beaker. Place the beaker in a dual-function air bath constant temperature oscillator and oscillate for 1.5 h at 50 ° C and 200 r / min to prepare 80 mg / mL sodium alginate building block solution;

[0117] 2. Weigh 0.12 g of hyaluronic acid into a centrifuge tube, add 40 mL of deionized water, and stir to mix evenly at 35°C to prepare a 3 mg / mL hyaluronic acid building block solution;

[0118] 3. Dissolve LL-37 in deionized water. The concentrations of LL-37 are 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 1.75, and 2.00 mg / mL, respectively;

[0119] 4. Immerse the treated biodegradable substrate into a 40°C sodium alginate building element solution, let it stand for 1 hour, and then take out the substrate;

[0120] 5. Immerse the substrate taken out in step 4 into a 20°C hyaluronic acid building element solution, let it stand for 30 minutes, and then take out the substrate;

[0121] 6. Immerse the substrate taken out in step 5 into the LL-37 solution, let it stand at room temperature overnight, then take out the substrate, wash off the unattached LL-37 molecules on the surface of the substrate with deionized water, and place the substrate on a sterile table to dry, thereby preparing a uniform antibacterial coating on the degradable substrate.

[0122] Example 5

[0123] Preparation of composite antibacterial coating of sodium alginate, hyaluronic acid and vancomycin by layer-by-layer assembly technology:

[0124] 1. Take 200 mL of deionized water in a beaker, then weigh 16 g of sodium alginate and add it to the beaker. Place the beaker in a dual-function air bath constant temperature oscillator and oscillate for 1.5 h at 50 ° C and 200 r / min to prepare 80 mg / mL sodium alginate building block solution;

[0125] 2. Weigh 0.12 g of hyaluronic acid into a centrifuge tube, add 40 mL of deionized water, and stir to mix evenly at 35°C to prepare a 3 mg / mL hyaluronic acid building block solution;

[0126] 3. Dissolve vancomycin in deionized water. The concentrations of vancomycin are 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 1.75, and 2.00 mg / mL respectively;

[0127] 4. Immerse the treated biodegradable substrate into a 40°C sodium alginate building element solution, let it stand for 1 hour, and then take out the substrate;

[0128] 5. Immerse the substrate taken out in step 4 into a 20°C hyaluronic acid building element solution, let it stand for 30 minutes, and then take out the substrate;

[0129] 6. Immerse the substrate taken out in step 5 in the vancomycin solution, let it stand at room temperature overnight, then take out the substrate, wash off the unattached vancomycin molecules on the surface of the substrate with deionized water, and place the substrate on a sterile table to dry, thereby preparing a uniform antibacterial coating on the degradable substrate.

[0130] Example 6. Field emission scanning electron microscopy experiment

[0131] The composite antibacterial coating of sodium alginate and antimicrobial peptide (LL-37) was prepared by dip coating and layer-by-layer assembly technology respectively:

[0132] S1. Take 5000g of PLA particles with a molecular weight of 100000 and prepare a block material of the desired size and thickness through a rotary rheometer;

[0133] S2. Take the block material obtained in S1 and trim it into the desired shape according to the corresponding mold, and then polish, ultrasonically clean and dry it to obtain a biodegradable substrate that can be used for medical implants / fillers for standby use;

[0134] S3. Take the block material obtained in S2 and immerse it in a 10 mg / mL sodium alginate building element solution, let it stand at 30°C for 30 minutes, and then take out the substrate;

[0135] S4-1. Take the block material obtained in S3 and immerse it in a 1 mg / mL LL-37 solution, let it stand at room temperature overnight, then remove the substrate, clean the unattached LL-37 molecules on the surface, dry it on a sterile bench and set it aside;

[0136] S4-2. Take the block material obtained in S3 and immerse it in a 1 mg / mL hyaluronic acid building block solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0137] S5. Take the block material obtained in S4-2 and immerse it in a 1 mg / mL LL-37 solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0138] S6 After repeating steps S4-2-S5 for 10 times, the substrate is taken out, and the unattached LL-37 molecules on the substrate surface are washed off with deionized water, and the substrate is placed on a sterile table to dry, thus preparing a sustainable release antibacterial coating on the degradable substrate.

[0139] S7. The morphology of the bulk materials obtained from S2, S4-1, and S6 was characterized by field emission scanning electron microscopy (FE-SEM). All samples were coated with gold for 1 minute before SEM observation. The results obtained correspond to Figure 1 A, B1, B2. Figure 1 It can be seen that the antimicrobial peptides were successfully coated onto the surface of the degradable substrate.

[0140] Example 7. Bacterial plating experiment

[0141] Preparation of composite antibacterial coating of sodium alginate and antimicrobial peptide (LL-37) by dip coating:

[0142] S1. Take 5000g of PLA particles with a molecular weight of 100000 and prepare a block material of the desired size and thickness through a rotary rheometer;

[0143] S2. Take the block material obtained in S1 and trim it into a desired shape according to the corresponding mold, then polish, ultrasonically clean and dry it to obtain a biodegradable substrate that can be used for medical implants / fillers for later use.

[0144] S3. Take the block material obtained in S2 and immerse it in a 10 mg / mL sodium alginate building element solution, let it stand at 30°C for 30 minutes, and then take out the substrate;

[0145] S4. Take the block material obtained in S3 and immerse it in 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, and 2.0 mg / mL LL-37 solutions respectively, let it stand at room temperature overnight, then take out the substrate, clean the unattached LL-37 molecules on the surface, dry it on a sterile bench and set it aside;

[0146] S5. Mix the bulk material obtained in S4 with 200 μL of 2×10 5 After incubation with Staphylococcus aureus at 400 CFU / mL for 24 hours, the solid material was placed in a 1.5 mL PE tube, 1.0 mL PBS was added, and the tube was eluted and incubated at 37°C and 200 r / min for 4 hours. Then 10 μL of the eluate was taken for plating, and the bacterial growth was observed after incubation in a 37°C incubator for 24 hours.

[0147] The results are as follows Figure 2 The results show that the prepared antibacterial material has a stable antibacterial effect.

[0148] Example 8. Bacterial plating experiment

[0149] Preparation of composite antibacterial coating of sodium alginate and antimicrobial peptide (LL-37) by layer-by-layer assembly technology:

[0150] S1. Take 5000g of PLA particles with a molecular weight of 100000 and prepare a block material of the desired size and thickness through a rotary rheometer;

[0151] S2. Take the block material obtained in S1 and trim it into the desired shape according to the corresponding mold, then polish, ultrasonically clean and dry it to obtain a biodegradable substrate that can be used for medical implants / fillers for later use.

[0152] S3. Take the block material obtained in S2 and immerse it in a 10 mg / mL sodium alginate building element solution, let it stand at 30°C for 30 minutes, and then take out the substrate;

[0153] S4. Take the block material obtained in S3 and immerse it in 1 mg / mL hyaluronic acid building block solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0154] S5. Take the block material obtained in S4 and immerse it in a 1 mg / mL LL-37 solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0155] S6. After repeating steps S4-S5 for 10 times, the coatings of the 1st, 3rd, 5th, 6th, 7th, 8th, 9th and 10th layers of the substrate are taken out, and the unattached LL-37 molecules on the surface of the substrate are washed off with deionized water. The substrate is placed on a sterile table to dry for later use, and a sustainable-release antibacterial coating is prepared on the degradable substrate.

[0156] S7. Mix the bulk material obtained in S6 with 200 μL of 2×10 5 After incubation with Staphylococcus aureus at 100 CFU / mL for 24 hours, the solid material was placed in a 1.5 mL PE tube, 1.0 mL PBS was added for elution and incubated for 4 hours (37°C, 200 rpm), and 10 μL of the eluate was taken for plate coating. After incubation in a 37°C incubator for 24 hours, the bacterial growth was observed.

[0157] The results are as follows Figure 3 The results show that the prepared antibacterial material has a sustained release antibacterial effect.

[0158] Example 9. Experiment of co-cultivation with Staphylococcus aureus

[0159] The composite antibacterial coating of sodium alginate and antimicrobial peptide (LL-37) was prepared by dip coating and layer-by-layer assembly technology respectively:

[0160] S1. Take 5000g of PLA particles with a molecular weight of 100000 and prepare a block material of the desired size and thickness through a rotary rheometer;

[0161] S2. Take the block material obtained in S1 and trim it into a desired shape according to the corresponding mold, then polish, ultrasonically clean and dry it to obtain a biodegradable substrate that can be used for medical implants / fillers for later use.

[0162] S3. Take the block material obtained in S2 and immerse it in a 10 mg / mL sodium alginate building element solution, let it stand at 30°C for 30 minutes, and then take out the substrate;

[0163] S4-1. Take the block material obtained in S3 and immerse it in 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.0 mg / mL LL-37 solution, let it stand at room temperature overnight, then remove the substrate, clean the unattached LL-37 molecules on the surface, dry it on a sterile bench and set it aside;

[0164] S4-2. Take the block material obtained in S3 and immerse it in a 1 mg / mL hyaluronic acid building block solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0165] S5. Take the block material obtained in S4-2 and immerse it in 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.0 mg / mL LL-37 solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0166] S6. After repeating steps S4-2 and S5 for 10 times, the substrate is taken out, and the unattached LL-37 molecules on the substrate surface are washed off with deionized water. The substrate is placed on a sterile bench to dry for later use.

[0167] S7. Take the block materials obtained in S4-1 and S6 and place them in a 96-well plate. Add 200 μL of 2×10 5 CFU / mL of Staphylococcus aureus liquid, and for the liquid sample to be tested, 180 μL of a 2×10 5 The S. aureus bacterial solution with a concentration of CFU / mL was then placed in a 37°C constant temperature incubator for 24 hours, and finally the light absorption value of the bacterial solution at 600nm was detected using an enzyme marker.

[0168] The experimental results are as follows Figure 4 ,Compared with pure antibacterial agents, it was shown that the antibacterial materials prepared by ,the dip-coating method and the layer-by-layer assembly preparation technology both had ,good antibacterial effects.

[0169] Example 10. Blood compatibility assessment test

[0170] S1. Take 5000g of PLA particles with a molecular weight of 100000 and prepare a block material of the desired size and thickness through a rotary rheometer;

[0171] S2. Take the block material obtained in S1 and trim it into a desired shape according to the corresponding mold, then polish, ultrasonically clean and dry it to obtain a biodegradable substrate that can be used for medical implants / fillers for later use.

[0172] S3. Take the block material obtained in S2 and immerse it in a 10 mg / mL sodium alginate building element solution, let it stand at 30°C for 30 minutes, and then take out the substrate;

[0173] S4-1. Take the block material obtained in S3 and immerse it in a 1 mg / mL LL-37 solution, let it stand overnight, then remove the substrate, clean the unattached LL-37 molecules on the surface, dry it on a sterile bench and set it aside;

[0174] S4-2. Take the block material obtained in S3 and immerse it in a 1 mg / mL hyaluronic acid building block solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0175] S5. Take the block material obtained in S4-2 and immerse it in a 1 mg / mL LL-37 solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0176] S6. After repeating steps S4-2 and S5 for 10 times, the substrate is taken out, and the unattached LL-37 molecules on the substrate surface are washed off with deionized water. The substrate is placed on a sterile bench to dry for later use.

[0177] S7. Healthy blood of volunteers was drawn and human red blood cells were separated from the whole blood. Red blood cells were separated by centrifugation (at 25°C, 4000rpm for 5 minutes), washed 4 times with PBS (pH=7.40) (the first 3 times were washed in a 50mL centrifuge tube, centrifugation conditions: at 25°C, 3900rpm for 8 minutes, the fourth time was washed in a 1.5mL centrifuge tube, centrifugation conditions: at 25°C, 4000rpm for 5 minutes), and then 200uL of the red blood cells precipitated at the bottom were resuspended in 10mL PBS solution to a specific volume level of 2%. The block materials obtained from S4-1 and S6 were immersed in 250 μL PBS and 250 μL red blood cell suspension, respectively, with 250 μL PBS and 250 μL red blood cell suspension as blank controls, 250 μL 10% Triton-X100 and 250 μL red blood cell suspension as positive controls, and 250 μL PBS, and then incubated at 37°C for 3 and 24 hours. After incubation, all tubes were centrifuged at 25°C, 4000 rpm for 5 minutes, and the supernatant was carefully removed and transferred to a new 96-well plate. The hemoglobin content in the supernatant was determined spectrophotometrically at 450 nm using an ELISA reader. The hemolysis percentage was calculated using the following formula:

[0178] Hemolysis rate = (ab) / (cb)×100%

[0179] Where a is the optical density (OD) value of the sample at 450 nm, b is the OD of the blank control at 450 nm (incubated with PBS, i.e. PBS+blood), and c is the OD of 100% hemolysis (incubated with Triton-X100, i.e. 10% Triton+blood, positive control).

[0180] The experimental results are as follows Figure 5The results show that the hemolysis rates of the antibacterial materials prepared by the dip-coating method and the layer-by-layer assembly preparation technology were lower than 5% and even lower than 1% after 3 hours and 24 hours in the red blood cell suspension, indicating that the prepared antibacterial materials had no hemolysis phenomenon and good biocompatibility.

[0181] Example 11. Water contact angle evaluation test

[0182] (1) Experimental group: The composite antibacterial coating of sodium alginate and antimicrobial peptide (LL-37) was prepared by dip coating and layer-by-layer assembly technology respectively:

[0183] S1. Take 5000g of PLA particles with a molecular weight of 100000 and prepare a block material of the desired size and thickness through a rotary rheometer;

[0184] S2. Take the block material obtained in S1 and trim it into a desired shape according to the corresponding mold, then polish, ultrasonically clean and dry it to obtain a biodegradable substrate that can be used for medical implants / fillers for later use.

[0185] S3. Take the block material obtained in S2 and immerse it in a 10 mg / mL sodium alginate building element solution, let it stand at 30°C for 30 minutes, and then take out the substrate;

[0186] S4-1. Take the block material obtained in S3 and immerse it in a 1 mg / mL LL-37 solution, let it stand at room temperature overnight, then remove the substrate, clean the unattached LL-37 molecules on the surface, dry it on a sterile bench and set it aside;

[0187] S4-2. Take the block material obtained in S3 and immerse it in a 1 mg / mL hyaluronic acid building block solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0188] S5. Take the block material obtained in S4-2 and immerse it in a 1 mg / mL LL-37 solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0189] S6. After repeating steps S4-2 and S5 for 10 times, the 1st, 3rd, 5th, 7th, 9th and 10th layers of the coating are taken out, and the unattached LL-37 molecules on the surface of the substrate are washed off with deionized water. The substrate is placed on a sterile table to dry for later use, and a sustainable-release antibacterial coating is prepared on the degradable substrate.

[0190] (2) Control group: Composite antibacterial coatings of chitosan and antimicrobial peptide (LL-37) were prepared using layer-by-layer assembly technology:

[0191] S1. Take 5000g of PLA particles with a molecular weight of 100000 and prepare a block material of the desired size and thickness through a rotary rheometer;

[0192] S2. Take the block material obtained in S1 and trim it into a desired shape according to the corresponding mold, then polish, ultrasonically clean and dry it to obtain a biodegradable substrate that can be used for medical implants / fillers for later use.

[0193] S3. Take the block material obtained in S2 and immerse it in a 5 mg / mL chitosan building element solution, let it stand at room temperature for 30 minutes, and then take out the substrate;

[0194] S4. Take the block material obtained in S3 and immerse it in a 0.5 mg / mL hyaluronic acid building block solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0195] S5. Take the block material obtained in S4 and immerse it in a 1 mg / mL LL-37 solution, let it stand at room temperature for 8 minutes, and then take out the substrate;

[0196] S6. After repeating steps S4-S5 for 10 times, the 1st, 3rd, 5th, 7th, 9th and 10th layers of the coating are taken out, and the unattached LL-37 molecules on the surface of the substrate are washed off with deionized water. The substrate is placed on a sterile table to dry and set aside. Thus, a sustainable-release antibacterial coating is prepared on the degradable substrate.

[0197] (3) Test method: The contact angle was measured using a contact angle meter (JY-PHa, Chengde Jinhe Instrument Manufacturing Co., Ltd.) at room temperature with 5 μL of ultrapure water as a wetting agent. Three points were selected on each side of the prepared antibacterial material to measure the water contact angle. Each material was measured three times in parallel, and the average value was taken.

[0198] The results are as follows Figure 6 The results show that compared with the sustainable release antibacterial material assembled by chitosan and hyaluronic acid, the sustainable release antibacterial material assembled by sodium alginate and hyaluronic acid has a smaller water contact angle and better hydrophilicity as the number of assembly layers increases.

[0199] The technical solution of the present invention is not limited to the above-mentioned specific embodiments. All technical variations made according to the technical solution of the present invention fall within the protection scope of the present invention.

Claims

1. An antibacterial material, comprising a substrate, an antibacterial agent layer, and a polyanion layer located between the substrate and the antibacterial agent layer, wherein the polyanion material in the polyanion layer comprises sodium alginate.

2. The antibacterial material according to claim 1, characterized in that: The polyanion material in the polyanion layer further comprises hyaluronic acid.

3. The antibacterial material according to claim 1 or 2, characterized in that: The substrate comprises a biodegradable polymer material, preferably, the substrate comprises a biodegradable polymer material with a molecular weight of 10,000-5,000,000, more preferably, the substrate comprises one or more of polylactic acid (PLA), carbon dioxide polymer (PPC), polybutylene succinate (PBS), fatty aromatic polyester Ecoflex (PBAT), polytrimethylene terephthalate (PPT), poly-β-hydroxyalkanoate (PHA), poly-ε-caprolactone (PCL) or polydioxanone (PPDO); and / or The antimicrobial agent in the antimicrobial agent layer includes one or more of antimicrobial peptides, glycopeptide antibiotics or macrolide antibiotics; preferably, the antimicrobial agent is selected from antimicrobial agents with a net positive charge, more preferably, the glycopeptide antibiotics include one or more of vancomycin, norvancomycin, teicoplanin, polymyxin B, colistin or bacitracin; more preferably, the macrolide antibiotics include one or more of erythromycin, spiramycin, josamycin, roxithromycin, clarithromycin or azithromycin; and / or The polyanion material in the polyanion layer also includes one or more of polyacrylic acid, sulfonated dextran, sulfonated polyetheretherketone, polystyrene sulfonic acid or their salts. Preferably, the salt is selected from one or more of lithium salt, sodium salt, potassium salt, calcium salt, magnesium salt, aluminum salt, iron salt, zinc salt or ammonium salt.

4. The antibacterial material according to any one of claims 1 to 3, characterized in that: The antimicrobial material comprises one or more polyanion layers; and / or The antimicrobial material comprises one or more layers of antimicrobial agent; Preferably, the one or more polyanion layers are spaced apart from the one or more antimicrobial agent layers; Preferably, the antibacterial material comprises a polyanion layer containing sodium alginate and an antibacterial agent layer sequentially stacked on a substrate; Preferably, the antibacterial material comprises a polyanion layer containing sodium alginate and a combined layer formed by a polyanion layer containing hyaluronic acid and an antibacterial agent layer sequentially stacked on a substrate; More preferably, the number of layers of the combined layer is 1-30 layers, preferably 2-10 layers.

5. A method for preparing the antibacterial material according to any one of claims 1 to 4, comprising sequentially coating a polyanion layer and an antibacterial agent layer on a substrate.

6. The preparation method according to claim 5, characterized in that: The preparation method comprises coating a polyanion layer and an antimicrobial agent layer on a substrate by dip coating, wherein the polyanion material in the polyanion layer comprises sodium alginate; Preferably, the preparation method comprises the following steps: A1: providing a building block solution containing a polyanion material and an antimicrobial agent solution containing an antimicrobial agent; A2: immersing the substrate in the building element solution; A3: Immersing the substrate obtained in A2 in the antibacterial agent solution to obtain the antibacterial material; more preferably, in step A1, the mass concentration of the polyanion material in the building block solution is 5-200 mg / mL, preferably 10-80 mg / mL; More preferably, in step A1, the mass concentration of the antibacterial agent is 0.05-25.00 mg / mL, preferably 0.25-2 mg / mL; More preferably, in step A2, the immersion temperature is 25-45°C and the time is 0.5-1.5h; More preferably, in step A3, the immersion temperature is 15-35°C and the time is 6-24h; More preferably, step A3 further comprises washing and drying the impregnated substrate.

7. The preparation method according to claim 5, characterized in that: The preparation method comprises coating a polyanion layer and an antibacterial agent layer on a substrate by layer-by-layer assembly, wherein the polyanion material in the polyanion layer comprises sodium alginate and hyaluronic acid; Preferably, the preparation method comprises the following steps: B1: providing a first building block solution containing a first polyanion material, a second building block solution containing a second polyanion material, and an antibacterial agent solution containing an antibacterial agent, wherein the first polyanion material comprises sodium alginate, and the second polyanion material comprises hyaluronic acid; B2: immersing the substrate in the first building element solution; B3: immersing the substrate obtained in B2 in the second building block solution; B4: immersing the substrate obtained in B3 in the antibacterial agent solution; B5: Repeat steps B3-B4 to obtain the antibacterial material; More preferably, B3-B4 is repeated 1-30 times, preferably 2-10 times; More preferably, in step B1, in the first building block solution, the mass concentration of the first polyanion material is 5-200 mg / mL, preferably 10-80 mg / mL; in the second building block solution, the mass concentration of the second polyanion material is 0.1-50 mg / mL, preferably 1-10 mg / mL; More preferably, in step B1, the mass concentration of the antibacterial agent is 0.05-25.00 mg / mL, preferably 0.25-2 mg / mL; More preferably, in step B2, the immersion temperature is 25-35°C and the time is 30-60min; More preferably, in step B3, the immersion temperature is 15-35°C and the time is 4-30 min; More preferably, in step B4, the immersion temperature is 15-35°C and the time is 4-30min; More preferably, step B5 further comprises washing and drying the impregnated substrate.

8. The preparation method according to claim 5 or 6, characterized in that: In step A1, in the presence of a solvent, a polyanion material is prepared at 25-50° C. to obtain a building block solution; and / or In step A1, in the presence of a solvent, an antibacterial agent is prepared at 15-35° C. to obtain an antibacterial agent solution; and / or In step B1, in the presence of a solvent, the first polyanion material is prepared at 25-50° C. to obtain a first building block solution, and / or the second polyanion material is prepared at 15-35° C. to obtain a second building block solution; and / or In step B1, in the presence of a solvent, an antimicrobial agent is prepared at 15-35° C. to obtain an antimicrobial agent solution; Preferably, the solvent comprises one or more of water, ethanol, acetic acid, acetic acid, hydrochloric acid or Tris; More preferably, the solvent of the antibacterial agent is selected from water.

9. The preparation method according to any one of claims 5 to 8, characterized in that: The substrate is obtained by polishing, cleaning and drying a substrate material in a desired shape; Preferably, the substrate material is prepared to a desired size and thickness by a rotary rheometer at 150-200°C; Preferably, 400-2000 grit sandpaper is used for polishing.

10. Use of the antibacterial material according to any one of claims 1 to 4 or the antibacterial material obtained by the preparation method according to any one of claims 5 to 9 in medical implants or medical fillers, preferably in tissue engineering scaffold materials, fracture internal fixation materials, and ophthalmic implant materials.